• BASF's October 28 third-quarter 2026 earnings call featured Markus Kamieth and Dirk Elvermann answering analysts' questions.
• Kamieth identified Evonik as the preferred acquisition target but stressed the strategy would work without an acquisition.
• Capital spending is expected at €2.8 billion–€2.9 billion; the four-year investment target remains €13 billion.
• Free cash flow guidance remains unchanged, supported by expected strong fourth-quarter collections, though achieving the range depends largely on feedstock prices.
• Elvermann expects 2027 restructuring costs to match or slightly exceed this year's level as transformation measures continue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BASF SE published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.